Management of kidney disease with ayurvedic treatment.

Completed

Conditions: Chronic kidney disease, stage 2 (mild). Ayurveda Condition: MUTRAVAHASROTOVIKARAH,

Registration Number: CTRI/2023/03/050945

Lead Sponsor: J S AYURVED MAHAVIDYALAYA

Brief Summary: The present study is a open labelled clinical study assessing the effectiveness of Ayurveda treatment for patients with chronic kidney disease (CKD) with serum creatinine levels between 1.4 mg/dL and 3.0 mg/dL. Conducted with 20 patients from the IPD of P. D. Patel Ayurveda Hospital, Nadiad, the study employed Shodhana Treatment (Virechana Karma and Niruha Basti) and specific oral formulations including Varunadi kwatha, Gokshuradiguggulu and Rasayana churna aimed at restoring Mutravaha Srotas functions and rejuvenating renal tissues. Findings showed significant improvements, with a marked reduction in symptoms such as edema and general weakness and an increase in kidney function markers, including eGFR and reduction in Serum creatinine, Blood urea and urine albumin . The study suggests that Ayurvedic treatments may decelerate CKD progression, potentially delaying the need for renal replacement therapy.

Detailed Description: Not available

Recruitment & Eligibility

Status: Completed

Sex: All

Target Recruitment: 20

Inclusion Criteria

1.PATIENTS HAVING SERUM CREATININE LEVEL BETWEEN 1.4 MG/DL TO 3.0 MG/DL 2.PATIENTS INDICATED FOR VIRECHANA KARMA AND BASTI KARMA.

Exclusion Criteria

1.FEMALE PATIENTS HAVING PREGNANCY, BREAST FEEDING OR POST-DELIVERY PERIOD 2.PATIENTS OF END STAGE KIDNEY DISEASE 3.PATIENTS WHO ARE ON DIALYSIS TREATMENT 4.PATIENTS WHO HAVING PREVIOUS HISTORY OF RENAL TRANSPLANTATION 5.PATIENTS OF HEPATO-RENAL INSUFFICIENCY OR RENAL INSUFFICIENCY DUE TO HAEMODYNEMIC CIRCULATORY DISORDERS AND CCF 6.PATIENTS WITH SOME SERIOUS ILLNESS LIKE CARDIO-VASCULAR DISEASES, PSYCHOLOGICAL DISORDERS, SERIOUS ACUTE ORGANIC DISEASES, SERIOUS CHRONIC CO-MORBIDITIES, LIVER DISORDERS OR METABOLIC DISORDERS ETC 7.PATIENTS WITH ANY BLEEDING DISORDERS 8.PATIENTS CONTRAINDICATED FOR VIRECHANA KARMA AND BASTI KARMA.

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
PRIMARY OUTCOME WILL BE RELIEF IN SIGNS, SYMPTOMS AND ASSESSMENT WILL BE DONE WITH THE HELP OF CHANGES IN HB EGFR SERUM CREATININE BLOOD UREA SERUM ELECTROLYTES (SODIUM, POTASSIUM, CHLORIDE) SERUM CALCIUM SERUM PHOSPHATE URINE ROUTINE AND MICROSCOPIC.	38-42 DAYS

Secondary Outcome Measures

Name	Time	Method
SECONDARY OUTCOME WILL BE IMPROVEMENT IN THE KIDNEY FUNCTION OF THE PATIENTS	every 15 days up to 2 months

Trial Locations

Locations (1): P D PATEL AYURVEDA HOSPITAL
🇮🇳
Kheda, GUJARAT, India
P D PATEL AYURVEDA HOSPITAL
🇮🇳Kheda, GUJARAT, India
Dr Kaushal D Patel
Principal investigator
7016292581
patelkaushal6372@gmail.com